224 related articles for article (PubMed ID: 36158031)
1. Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease.
Yasmin F; Najeeb H; Naeem U; Moeed A; Koritala T; Surani S
World J Clin Cases; 2022 Jul; 10(21):7195-7208. PubMed ID: 36158031
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte and monocyte adsorptive apheresis (GMA) in patients with inflammatory bowel disease: A useful therapeutic tool not just in ulcerative colitis but also in Crohn's disease.
Fernández-Pérez FJ; Fernández-Moreno N; Soria-López E; Rodriguez-González FJ; Fernández-Galeote FJ; Lifante-Oliva A; Ruíz-Hernández C; Escalante-Quijaite E; Rivas-Ruiz F
Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38710467
[TBL] [Abstract][Full Text] [Related]
4. Cytapheresis.
Yokoyama Y; Kamikozuru K; Nakamura S
Nihon Rinsho; 2017 Mar; 75(3):419-425. PubMed ID: 30566785
[TBL] [Abstract][Full Text] [Related]
5. Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases - a case report and literature review.
Mastronardi M; Cavalcanti E; Labarile N; Armentano R; Gabriele F; Curlo M
Ther Adv Chronic Dis; 2023; 14():20406223231194190. PubMed ID: 37928629
[TBL] [Abstract][Full Text] [Related]
6. Ulcerative colitis with hepatitis B virus infection treated successfully by granulocyte monocyte apheresis.
Saito H; Hanafusa N; Kishikawa J; Noiri E; Sunami E; Ishihara S; Watanabe T; Nangaku M
J Clin Apher; 2016 Dec; 31(6):584-586. PubMed ID: 26876484
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte and monocyte/macrophage apheresis in paediatric patients with ulcerative colitis: a case series in Spain.
de Carpi JM
Drugs Context; 2022; 11():. PubMed ID: 35371271
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
[TBL] [Abstract][Full Text] [Related]
9. Retrospective Single Center Study of Granulocyte Monocyte Adsorption Apheresis Treatment in Inflammatory Bowel Disease.
Edfors K; Ståhlberg D; Söderman C
Ther Apher Dial; 2016 Feb; 20(1):79-85. PubMed ID: 26841133
[TBL] [Abstract][Full Text] [Related]
10. Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future.
Chen XL; Mao JW; Wang YD
World J Gastrointest Pathophysiol; 2020 May; 11(3):43-56. PubMed ID: 32435521
[TBL] [Abstract][Full Text] [Related]
11. Targeting neutrophils in inflammatory bowel disease: revisiting the role of adsorptive granulocyte and monocyte apheresis.
Bamias G; Zampeli E; Domènech E
Expert Rev Gastroenterol Hepatol; 2022 Aug; 16(8):721-735. PubMed ID: 35833363
[TBL] [Abstract][Full Text] [Related]
12. Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.
Saniabadi AR; Tanaka T; Ohmori T; Sawada K; Yamamoto T; Hanai H
World J Gastroenterol; 2014 Aug; 20(29):9699-715. PubMed ID: 25110409
[TBL] [Abstract][Full Text] [Related]
13. Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis.
Hanai H
World J Gastroenterol; 2006 Dec; 12(47):7568-77. PubMed ID: 17171783
[TBL] [Abstract][Full Text] [Related]
14. The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study.
Passalacqua S; Ferraro PM; Bresci G; D'Ovidio V; Astegiano M; Principi M; Testa R; D'Incà R; Valpiani D; Armuzzi A; Sablich R; Cavallaro F; Costa F; Di Leo V; Colombo E; Santini A; Aratari A; Lecis P; Saladino V; Riegler G; Marco M; Calella F; Ricci C; Guidi ML; Repaci G; Silla M
J Clin Apher; 2011 Dec; 26(6):332-7. PubMed ID: 22072543
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults.
Leitner GC; Vogelsang H
World J Gastrointest Pharmacol Ther; 2016 Feb; 7(1):5-20. PubMed ID: 26855808
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-monocyte adsorptive apheresis in pediatric inflammatory bowel disease: results, practical issues, safety, and future perspectives.
Ruuska T; Wewer V; Lindgren F; Malmborg P; Lindquist M; Marthinsen L; Browaldh L; Casswall T; Kalliomäki M; Grönlund J
Inflamm Bowel Dis; 2009 Jul; 15(7):1049-54. PubMed ID: 19137602
[TBL] [Abstract][Full Text] [Related]
17. Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study.
Motoya S; Tanaka H; Shibuya T; Osada T; Yamamoto T; Hongo H; Mizuno C; Saito D; Aoyama N; Kobayashi T; Ito H; Tanida S; Nojima M; Kokuma S; Hosoi E
BMC Gastroenterol; 2019 Nov; 19(1):196. PubMed ID: 31752695
[TBL] [Abstract][Full Text] [Related]
18. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-monocyte apheresis: an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis.
Rodríguez-Lago I; Sempere L; Gutiérrez A; Núñez A; Leo Carnerero E; Hinojosa E; Mora M; Cañete F; Mañosa M; Herrera C; Beltrán B; Forés A; Arjona D; Barreiro-de Acosta M; Khorrami S; Aguirre U; Ginard D; Cabriada JL
Scand J Gastroenterol; 2019 Apr; 54(4):459-464. PubMed ID: 30982369
[No Abstract] [Full Text] [Related]
20. Current pharmacologic treatment paradigms for inflammatory bowel disease and the potential role of granulocyte/monocyte apheresis.
Schwartz D; Ferguson JR
Curr Med Res Opin; 2007 Nov; 23(11):2715-28. PubMed ID: 17894921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
